Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowance for losses of $1,190 and $1,129, respectively
Inventories
Net investment in leases, current, net of allowance for losses of $190 and $182, respectively
Prepaid expenses
Related party convertible note receivable, net
Other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Goodwill
Net intangible assets
Other intangible assets, net
Deferred tax asset, net
Net investment in leases, non-current
Investments in unconsolidated affiliates
Related party convertible note receivable, net
Promissory note receivable from investee, net
Other non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Current liabilities:
Accounts payable
Accrued liabilities
Accrued purchase consideration payable
Operating lease liabilities, current
Deferred revenue, current, and other
Total current liabilities
Convertible note, non-current, net
Notes payable
Deferred revenue, non-current
Other long-term borrowings
Related party loan
Operating lease liabilities, non-current
Deferred tax liability
Other liabilities
Total liabilities
Redeemable non-controlling interest and mezzanine equity
Stockholders' equity:
Preferred stock, $0.01 par value, 2,500,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value, 20,000,000 shares authorized, none issued or outstanding
Public common stock, $0.01 par value, 20,000,000 shares authorized, 10,915,679 and 10,829,518 shares issued and outstanding, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support